<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03452982</url>
  </required_header>
  <id_info>
    <org_study_id>SENTOV</org_study_id>
    <nct_id>NCT03452982</nct_id>
  </id_info>
  <brief_title>Sentinel Lymph Node in Early Ovarian Cancer</brief_title>
  <acronym>SENTOV</acronym>
  <official_title>Sentinel Lymph Node in Early Ovarian Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigacion Sanitaria La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigacion Sanitaria La Fe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study evaluates the concordance of the result between two diagnostic tests:
      Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with ovarian cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to describe the feasibility of performing the sentinel node
      technique (Detection rate) in patients with early stage ovarian cancer.

      With this research study it will be evaluated the concordance of the result between two
      diagnostic tests: Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with
      ovarian cancer.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Controlled, prospective, descriptive and not randomized</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of performing the sentinel node technique (Detection rate)</measure>
    <time_frame>Intraoperative (day 0)</time_frame>
    <description>The objective of this study is to describe the feasibility of performing the sentinel node technique (Detection rate) in patients with previous ovarian surgery injecting the tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of realization of the technique</measure>
    <time_frame>Intraoperative (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of realization of the technique</measure>
    <time_frame>After anatomopathological study (day 30)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomical location of the sentinel node(s)</measure>
    <time_frame>Intraoperative (day 0)</time_frame>
    <description>Assessed by radiation (99Tc-nanocoloides) and staining with indocyanine green</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomical location of the sentinel node(s)</measure>
    <time_frame>After anatomopathological study (day 30)</time_frame>
    <description>Assessed by the pathologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of detected sentinel nodes</measure>
    <time_frame>Intraoperative (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of detected sentinel nodes</measure>
    <time_frame>After anatomopathological study (day 30)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting baseline characteristics</measure>
    <time_frame>Screening (day 0)</time_frame>
    <description>Age (years)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting baseline characteristics</measure>
    <time_frame>Screening (day 0)</time_frame>
    <description>Weight (kilograms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting baseline characteristics</measure>
    <time_frame>Screening (day 0)</time_frame>
    <description>Height (centimeters)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting baseline characteristics</measure>
    <time_frame>Screening (day 0)</time_frame>
    <description>BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting baseline characteristics</measure>
    <time_frame>Screening (day 0)</time_frame>
    <description>Previous gynecological surgery and previous pathological anatomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting tumor markers</measure>
    <time_frame>Day 0</time_frame>
    <description>Ca 125 and Ca 19.9.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting intraoperative findings</measure>
    <time_frame>Day 0</time_frame>
    <description>Ascites (milliliters)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting intraoperative findings</measure>
    <time_frame>Day 0</time_frame>
    <description>Tumor size (centimeters) of: right ovary, left ovary, right tube, left tube, uterus, pelvic nodes, para-aortic nodes, and tumor in upper hemiabdomen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting surgical procedures</measure>
    <time_frame>Day 0</time_frame>
    <description>Hysterectomy, adnexectomy, appendectomy, peritonectomy / peritoneal biopsy, omentectomy, lymphadenectomy and blood transfusion (Realized or Unrealized)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting surgical procedures</measure>
    <time_frame>Day 0</time_frame>
    <description>Intraoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting surgical procedures</measure>
    <time_frame>Day 0</time_frame>
    <description>Result of intraoperative biopsy (unrealized, malignant, benign)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting surgical procedures</measure>
    <time_frame>Day 0</time_frame>
    <description>Estimated blood loss (milliliters)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of the sample by collecting surgical procedures</measure>
    <time_frame>Day 0</time_frame>
    <description>Surgical time (minutes)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with ovarian cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of a tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sentinel node technique</intervention_name>
    <description>Injection of a tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.</description>
    <arm_group_label>Patients with ovarian cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent signed previously to performing any procedure related to the clinical
             trial.

          -  Patients who are women 18 years of age or older at the moment of the randomization.

          -  Patients with anatomopathological diagnosis of malignant ovarian tumor in a deferred
             study proposals for staging surgery or patients with suspicious tumor of malignancy
             who are going to be subjected to exploratory lapaotomy or laparoscopy and operative
             biopsy, and in the case this is positive, surgery of staging will be performed .

        Exclusion Criteria:

          -  Informed consent not obtained or withdraw.

          -  Benign result in extemporaneous study

          -  Previous history of vascular surgery in the aorta, cava or pelvic vessels

          -  Previous pelvic or para-aortic lymphadenectomy

          -  Previous lymphoma

          -  Previous abdomino-pelvic tumor

          -  Previous allergic reaction to indocyanine green

          -  Pregnancy / lactation

          -  Severe adherent syndrome
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Lago</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Investigaci√≥n Sanitaria La Fe</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Cortell</last_name>
    <phone>961246611</phone>
    <email>investigacion_clinica@iislafe.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Segura</last_name>
    <phone>961246711</phone>
    <email>monitor1@iislafe.es</email>
  </overall_contact_backup>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SENTINEL LYMPH NODE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

